OncoTherapy Science Inc 4564.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 1:43 PM JST
66.00quote price arrow up+1.00 (+1.54%)
Volume
384,700
52 week range
62.00 - 111.00
Loading...
  • Open65.00
  • Day High66.00
  • Day Low64.00
  • Prev Close65.00
  • 52 Week High111.00
  • 52 Week High Date07/12/21
  • 52 Week Low62.00
  • 52 Week Low Date06/21/22

Key Stats

  • Market Cap91.36M
  • Shares Out192.64M
  • 10 Day Average Volume523,400
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-8.33

KEY STATS

  • Open65.00
  • Day High66.00
  • Day Low64.00
  • Prev Close65.00
  • 52 Week High111.00
  • 52 Week High Date07/12/21
  • 52 Week Low62.00
  • 52 Week Low Date06/21/22
  • Market Cap91.36M
  • Shares Out192.64M
  • 10 Day Average Volume523,400
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-8.33

RATIOS/PROFITABILITY

  • EPS (TTM)-8.30
  • P/E (TTM)-7.95
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On OncoTherapy Science Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
OncoTherapy Science, Inc. is a Japan-based company mainly engaged in the development of drugs. The Company is involved in the development of low molecular drugs, antibody drugs and other drugs, as well as the provision and clinical development of medical candidate substances. The Company operates its business in cooperation with universities and other corporations. The Company provides its licenses to pharmaceutical manufacturers. The Company also involves in T Cell...
Hatsuo Kato
Chairman of the Board
Jae Park
President, Chief Executive Officer, Chief Scientific Officer, President of Subsidiary, Representative Director
Address
6F, Kanagawa Science Park R&D Bldg. D
3-2-1, Sakado, Takatsu-ku
Kawasaki-shi, KNG
213-0012
Japan